Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000749

Director sold 50,477 shares at an average $17.81 ($899,216)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-03 Sale : show line 1 in the form −47,409 $17.77 $842,458 2,229,413 I
2017-08-04 Sale : show line 2 in the form −3,068 $18.50 $56,758 2,226,345 I
Open-market sales · 50,477 sh · avg $17.81 · $899,216
Loading xslF345X03/vonemster_fm4aug32017.xml…